STK17B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.394600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.918200E-01
Normal-vs-Stage2
4.505200E-01
Normal-vs-Stage3
3.971400E-01
Normal-vs-Stage4
4.587200E-01
Stage1-vs-Stage2
3.238800E-01
Stage1-vs-Stage3
8.881800E-01
Stage1-vs-Stage4
2.476400E-01
Stage2-vs-Stage3
4.713000E-01
Stage2-vs-Stage4
9.381400E-01
Stage3-vs-Stage4
2.475200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.406600E-01
Normal-vs-AfricanAmerican
4.910600E-01
Normal-vs-Asian
3.854800E-01
Caucasian-vs-AfricanAmerican
4.838400E-01
Caucasian-vs-Asian
5.462000E-02
AfricanAmerican-vs-Asian
7.203900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.352800E-01
Normal-vs-Female
4.459000E-01
Male-vs-Female
6.408800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.619800E-01
Normal-vs-Age(41-60Yrs)
4.686000E-01
Normal-vs-Age(61-80Yrs)
4.310800E-01
Normal-vs-Age(81-100Yrs)
4.026000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.452000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.788200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.379400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.482960E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.739900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.698600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.288600E-01
Normal-vs-Daily Drinker
4.169600E-01
Normal-vs-Weekly Drinker
4.070200E-01
Normal-vs-Occasional Drinker
4.327800E-01
Normal-vs-Social Drinker
4.233600E-01
Non Drinker-vs-Daily Drinker
7.682400E-01
Non Drinker-vs-Weekly Drinker
5.355800E-01
Non Drinker-vs-Occasional Drinker
9.199000E-01
Non Drinker-vs-Social Drinker
9.046800E-01
Daily Drinker-vs-Weekly Drinker
7.643000E-01
Daily Drinker-vs-Occasional Drinker
6.442400E-01
Daily Drinker-vs-Social Drinker
8.704000E-01
Weekly Drinker-vs-Occasional Drinker
4.269800E-01
Weekly Drinker-vs-Social Drinker
6.497000E-01
Occasional Drinker-vs-Social Drinker
7.974400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.580000E-01
Normal-vs-Grade 2
1.948380E-01
Normal-vs-Grade 3
1.656650E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.367600E-01
Grade 1-vs-Grade 3
7.101800E-01
Grade 1-vs-Grade 4
6.580000E-01
Grade 2-vs-Grade 3
1.524430E-01
Grade 2-vs-Grade 4
1.948380E-01
Grade 3-vs-Grade 4
1.656650E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.650600E-01
Normal-vs-NonDiabetic
4.158000E-01
Diabetic-vs-NonDiabetic
1.198960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.960200E-01
Normal-vs-NoPancreatitis
4.361000E-01
Pancreatitis-vs-NoPancreatitis
3.529600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.305600E-01
Normal-vs-N1
4.470600E-01
N0-vs-N1
5.521600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.718200E-01
Normal-vs-TP53-NonMutant
4.083600E-01
TP53-Mutant-vs-TP53-NonMutant
2.313200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
